Full Text View
Tabular View
No Study Results Posted
Related Studies
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
This study has been completed.
Study NCT00033007   Information provided by National Institute on Drug Abuse (NIDA)
First Received: April 5, 2002   Last Updated: June 11, 2009   History of Changes

April 5, 2002
June 11, 2009
April 2001
February 2003   (final data collection date for primary outcome measure)
  • ASI
  • Cocaine use
  • AIDS risk behavior
Same as current
Complete list of historical versions of study NCT00033007 on ClinicalTrials.gov Archive Site
 
 
 
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics

The purpose of this study is to test the utilization of incentive values (considerably lower than those typically used in research clinics) to motivate clients to attend treatment and initiate and sustain abstinence.

The purpose of the proposed research is to implement and systematically evaluate, in community treatment settings, motivational incentive procedures that have been well researched and have proven efficacious in a variety of treatment research clinics.

Phase III
Interventional
Treatment, Randomized
Substance-Related Disorders
Behavioral: Behavior Therapy
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
440
February 2003
February 2003   (final data collection date for primary outcome measure)

Inclusion Criterea:

  • New intake to a drug-free CTP
  • Evidence of cocaine or methamphetamine use, any reported use in past 2 weeks or positive urine screen at study intake. For those exiting a controlled environment, any stimulant use within two weeks of entering the controlled environment

Exclusion Criteria:

  • Unable to give informed consent (fails simple consent quiz)
  • Answers yes to question: Are you in recovery from gambling? That is, have you stopped gambling because of previous problems with gambling?
Both
 
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00033007
 
NIDA-CTN-0006-1
National Institute on Drug Abuse (NIDA)
Johns Hopkins University
Principal Investigator: Maxine Stitzer, Ph.D. Johns Hopkins University
National Institute on Drug Abuse (NIDA)
July 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP